On March 26th, 2018, Michael Frederick Freitag, Alterola Biotech Inc.'s President and CEO, and Krono Partners Limited completed a transaction with London Pharma Holdings Limited, which acquired 330,000 shares of common stock, representing 61.17% ownership of the Company. On March 26, 2018, Mr. Michael Frederick Freitag resigned from his official positions as Director and CEO of Alterola Biotech Inc., and on the same day the shareholders of the Corporation voted Mr. Peter Maddocks as Director, and CEO. Peter Maddocks, 59, is a Chartered Accountant who brings decades of executive corporate financial experience to the Company.

He has held positions at KPMG, was a senior financial controller with Citi Bank Private Banking in London, Citi Bank Italy and Citi Bank Venture Capital Emerging Markets Group. The Shareholders of the corporation at a special meeting, have elected PETER E. MADDOCKS as Director & CFO.